2014 Biotech Charity Contest Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2014 Biotech Charity Contest

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (290)	4/21/2014 8:29:07 PM
From: BulbaMan	Read Replies (4) of 487

Terrific idea, Rick! I’ll pick PGNX from my Contest portfolio. It hit a high of $7.45 on 1/17/14 and closed today (4/21) at $3.63 for a 51% drop. Market cap is $252 million and PGNX should have about $90 million in cash after their February PP, with no debt. PGNX has a promising PSMA prostate cancer pipeline, as well as a targeted radiotherapy program and the stock should get a pop once the FDA reschedules the Relistor Advisory Committee meeting. Here’s a link to their website: progenics.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next